Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04596241 · ClinicalTrials.gov registry record · NA
Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT04596241 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 34 participants.
The verdict
NCT04596241, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy and safety of the BTL-899 device for changes in subcutaneous fat tissue and muscle tissue of arms. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and two follow-up visits. All of the study subjects will receive the treatment with the subject device.
Interventions
- DEVICE BTL-899
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2020-10-05 |
| Est. Completion | 2022-02-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04596241
The ClinicalTrials.gov registry entry for NCT04596241 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 34 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-899 is the first listed.
NCT04596241 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04596241 about?
NCT04596241 is a clinical study titled "Non-invasive Lipolysis and Improvement of Muscle Tone in Upper Arms". This study will evaluate the clinical efficacy and safety of the BTL-899 device for changes in subcutaneous fat tissue and muscle tissue of arms. The study is a prospective multi-center open-label single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will b...
What is the current status of trial NCT04596241?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2020-10-05. Estimated completion is 2022-02-10.
What interventions are being tested in trial NCT04596241?
The interventions under investigation include: BTL-899 (DEVICE).
Who is sponsoring clinical trial NCT04596241?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.